A phase 1b/2 study of LEE011 in combination with binimetinib (MEK162) in patients with NRAS-mutant melanoma: Early encouraging clinical activity.-Reference-Cited by-同舟云学术

A phase 1b/2 study of LEE011 in combination with binimetinib (MEK162) in patients with NRAS-mutant melanoma: Early encouraging clinical activity.

Published:2014-05-20 Issue:15_suppl Volume:32 Page:9009-9009
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Sosman Jeffrey Alan¹,Kittaneh Muaiad²,Lolkema Martijn P. J. K.³,Postow Michael Andrew⁴,Schwartz Gary⁵,Franklin Catherine⁶,Matano Alessandro⁷,Bhansali Suraj⁸,Parasuraman Sudha⁹,Kim Kevin¹⁰

Affiliation:

1. Vanderbilt University Medical Center, Nashville, TN

2. Center for Translational Therapeutics, Karmanos Cancer Institute, Detroit, MI

3. University Medical Center Utrecht, Utrecht, Netherlands

4. Memorial Sloan Kettering Cancer Center, New York, NY

5. Columbia University Medical Center, New York, NY

6. Novartis Institutes for Biomedical Research, Cambridge, MA

7. Novartis Pharma AG, Basel, Switzerland

8. Novartis Pharmaceuticals, East Hanover, NJ

9. Novartis Pharmaceuticals Corporation, East Hanover, NJ

10. The University of Texas MD Anderson Cancer Center, Houston, TX

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2014.32.15_suppl.9009

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclin-Dependent Kinase 4/6 Inhibitors Against Breast Cancer;Mini-Reviews in Medicinal Chemistry;2023-03

2. Therapeutic Strategies for Targeting CDKN2A Loss in Melanoma;Journal of Investigative Dermatology;2023-01

3. Targeted Therapy for Melanomas Without BRAF V600 Mutation;Current Oncology Reports;2022-11-26

4. Escape from G1 arrest during acute MEK inhibition drives the acquisition of drug resistance;NAR Cancer;2022-09-28

5. Primary lacrimal sac melanoma: a case report describing the novel use of fine needle aspiration cytology (FNAC) for diagnosis, together with literature review and immunotherapy treatment update;Orbit;2022-09-07